Neotropix

Neotropix is a virtual biotechnology company based in Malvern, Pennsylvania. The company employs 4 people and generates $9 million in annual revenue. Neotropix specializes in developing naturally derived live viruses designed to target and destroy cancer cells. Their products are administered through a single intravenous infusion, which then spreads throughout the body, infecting tumor masses and regulating tumor growth. This approach aims to extend both progression-free survival and overall survival for patients diagnosed with small cell lung cancer, carcinoid cancer, and various pediatric cancers. Neotropix distinguishes itself through its innovative use of naturally derived live viruses as a cancer treatment. This unique approach offers a targeted and potentially more effective method for combating cancer compared to traditional therapies. For more information about Neotropix and its groundbreaking cancer treatments, please visit their website at neotropix.com.